Egetis Therapeutics AB (publ) Financial Flexibility Index
Egetis Therapeutics AB (publ) financial flexibility index. Egetis Therapeutics AB (publ) (EGTX) has a Financial Flexibility Index of -0.22x as of March 2026. Free cash flow of Skr-64.30 Million (operating CF Skr-64.30 Million minus capex Skr0.00) represents 0% of total liabilities (Skr288.70 Million). See EGTX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Egetis Therapeutics AB (publ) (2010–2025)
Financial flexibility index of Egetis Therapeutics AB (publ) from 2010 to 2025. Historical Financial Flexibility Index trend for Egetis Therapeutics AB (publ) across 16 annual periods. Check how high is Egetis Therapeutics AB (publ)'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
Egetis Therapeutics AB (publ) Financial Flexibility Index by Year (2010–2025)
Egetis Therapeutics AB (publ) financial flexibility index by year from 2010 to 2025. Year-by-year free cash flow to debt coverage for Egetis Therapeutics AB (publ). For the full cash flow conversion analysis, see Egetis Therapeutics AB (publ) (EGTX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.88x | Skr-265.60 Million | Skr-267.10 Million | Skr300.40 Million | ▼ -16.2% |
| 2024 | -0.76x | Skr-227.90 Million | Skr-227.90 Million | Skr299.40 Million | ▲ +41.3% |
| 2023 | -1.30x | Skr-278.40 Million | Skr-278.40 Million | Skr214.60 Million | ▲ +59.0% |
| 2022 | -3.16x | Skr-173.50 Million | Skr-173.50 Million | Skr54.90 Million | ▼ -2.7% |
| 2021 | -3.08x | Skr-129.94 Million | Skr-130.11 Million | Skr42.23 Million | ▼ -504.2% |
| 2020 | -0.51x | Skr-134.62 Million | Skr-134.64 Million | Skr264.34 Million | ▲ +79.5% |
| 2019 | -2.49x | Skr-62.62 Million | Skr-62.64 Million | Skr25.20 Million | ▲ +29.8% |
| 2018 | -3.54x | Skr-80.29 Million | Skr-80.31 Million | Skr22.68 Million | ▲ +52.3% |
| 2017 | -7.42x | Skr-86.53 Million | Skr-86.55 Million | Skr11.66 Million | ▼ -41.3% |
| 2016 | -5.25x | Skr-36.12 Million | Skr-36.12 Million | Skr6.87 Million | ▲ +55.5% |
| 2015 | -11.82x | Skr-51.15 Million | Skr-51.15 Million | Skr4.33 Million | ▼ -265.8% |
| 2014 | -3.23x | Skr-41.38 Million | Skr-41.38 Million | Skr12.81 Million | ▲ +53.3% |
| 2013 | -6.92x | Skr-28.07 Million | Skr-28.07 Million | Skr4.06 Million | ▼ -41.1% |
| 2012 | -4.90x | Skr-31.96 Million | Skr-31.96 Million | Skr6.52 Million | ▼ -283.2% |
| 2011 | -1.28x | Skr-4.98 Million | Skr-14.40 Million | Skr3.89 Million | ▼ -307.2% |
| 2010 | -0.31x | Skr-472.28K | Skr-2.72 Million | Skr1.50 Million | — |